MedTrace Logo

Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.

NCT03182517 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-06-27

No results posted yet for this study

Summary

Secondary hyperparathyroidism is an important complication in patient with chronic kidney disease . It is associated with bone complication and an increase in cardiovascular mortality The parathyroid hormone rises in these patients as consequence of low concentration of vitamin D3 ,reduction in quantities of serum calcium, phosphorus retention and reduction of vitamin D receptors sensitive to calcium.

Conditions

  • Chronic Kidney Diseases

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2018-08-31
Completion
2018-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182517 on ClinicalTrials.gov